Search Results - "De la Rubia Nieto, A"

PP-043 Evolution of costs in biological intravenous treatments in rheumatic diseases over 5 years by Franco, C Pellicer, de la Rubia Nieto, A

“…BackgroundRheumatic diseases generate considerable consumption of health resources due to the use of biological therapies, continuous monitoring of disease and…”
Get full text

4CPS-054 Early levels of vancomycin in intensive care unit (icu) protocol depending on icu patients’ characteristics by Pulido, M Valderrey, Sanchez, S Vicente, Vera, APareja Rodriguez de, Jimenez, ROlmos, Jimenez, MDMRuiz, Gómez, ARuiz, Nieto, A de la Rubia

“…BackgroundEfficacy of vancomycin in critical ill patients is highly related with adequate vancomycin blood levels, so a vancomycin protocol has been developed…”
Get full text

DD-004 Analysis of the causes of stock-out in small automated dispensing systems by de Palencia, MA Fernandez, Herrero, MR Garcia, Luiz, A Tomás, Jiménez, MM Ruiz, Contreras, MC Muñoz, de La Rubia Nieto, A

“…BackgroundSmall automated dispensing systems (ADS) have allowed improvements in the hospital drug distribution process. The pharmacy department is responsible…”
Get full text

DD-003 Assessment of indicators related to automated dispensing systems by de Palencia, MA Fernandez, Rueda, MM Galindo, Rivadeneyra, M Almanchel, Otero, F Mendoza, Molina, O Garcia, de La Rubia Nieto, A

“…BackgroundNew technologies have improved efficiency and safety of drug management in hospitals. From 2006 to 2009, six automated dispensing systems (ADS)…”
Get full text

DI-020 Clinical experience with dolutegravir in a tertiary hospital by Naranjo, L Menéndez, Rivadeneyra, M Almanchel, Contreras, MC Muñoz, González, A Mancebo, Garre, M Sanchez, Nieto, A de La Rubia

“…BackgroundDolutegravir has been marketed in Spain since last year. It is indicated, in combination with other antiretroviral medicinal products, for the…”
Get full text

CP-033 Evaluation of sofosbuvir plus daclatasvir combination for hepatitis C virus treatment by Naranjo, L Menéndez, Sanchez, S Vicente, Garre, M Sanchez, Contreras, MC Muñoz, Rivadeneyra, M Almanchel, de La Rubia Nieto, A

“…BackgroundThe development of direct acting antiviral agents (DAAs) represents a significant improvement in hepatitis C virus (HCV) treatment. Interferon free…”
Get full text

PP-021 Quality study of intravenous mixtures after the implementation of double check by Sánchez, S Vicente, Molina, O García, Pulido, M Valderrey, Contreras, MC Muñoz, Carmona, J Mateo, Nieto, A de La Rubia

“…BackgroundAvoiding errors related to drug development, which can compromise the patient’s life, is essential in our profession.PurposeTo describe the quality…”
Get full text

CP-175 Descriptive analysis of active clinical trials in cardiology service by Soler, JI García, de Vera, A Pareja Rodríguez, Casañ, V Arocas, Molina, OM García, Comendador, S Martínez, Lozano, E González, Luz, A Tomas, Jiménez, MDM Ruiz, Sánchez, S Vicente, De la Rubia Nieto, A

“…BackgroundCardiovascular diseases are the leading cause of death in Europe making it necessary to promote research projects.PurposeTo describe active…”
Get full text

Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease by Fernández de Palencia-Espinosa, M A, Cárceles-Barón, M D, Blázquez-Álvarez, M J, Arocas-Casañ, V, de la Rubia-Nieto, A

“…To describe the use of levosimendan for compassionate use in children undergoing surgery for congenital heart disease, as well as survival rates, and the…”
Get more information

4CPS-119 Effectiveness of capecitabine treatment in metastasic colorectal cancer in elderly patients by Soler, JI García, Molina, OM García, García, FJ Gómez, Lozano, E González, Jiménez, MDM Ruiz, Sánchez, S Vicente, Carrasco, A Laorden, Gómez, A Ruiz, Nieto, MA de la Rubia

“…BackgroundAge is the major risk factor for metastasic colorectal cancer (mCRC), with 70% of patients older than 70 years. Furthermore, elderly patients are not…”
Get full text

DI-022 Use and clinical experience of DOLUTEGRAVIR/ABACAVIR/LAMIVUDINA in a tertiary hospital by Sanchez, S Vicente, Naranjo, L Menendez, Pulido, M Valderrey, Jimenez, MDM Ruiz, Soler, JI Garcia, de la Rubia Nieto, MA

“…BackgroundThe new co-formulated drugs for HIV have made great strides in treating the disease and have achieved excellent health outcomes in patients.PurposeTo…”
Get full text

PS-032 Study of effectiveness and safety of ADALIMUMAB, ETANERCEPT and INFLIXIMAB in elderly patients with rheumatoid arthritis by Jiménez, MDM Ruíz, Molina, O García, Carmona, J Mateo, Soler, JI García, Lozano, E González, Comendador, S Martínez, De La Rubia Nieto, MA

“…BackgroundAlthough elderly patients with rheumatoid arthritis (RA) are probably the largest group of patients with RA, this age group has been excluded from…”
Get full text

PP-045 Evaluation of compounding quality of intravenous admixtures by Luiz, A Tomás, Franco, C Pellicer, Jimenez, MDM Ruiz, Rivadeneyra, M Almanchel, Carmona, J Mateo, Nieto, MA de La Rubia

“…BackgroundAccording to guides, it is necessary to ensure the compounding quality of intravenous admixtures in the pharmacy service.PurposeTo evaluate the…”
Get full text

CP-202 Safety and efectiveness of topical 10% n-acetylcysteine in 5% urea o/w emulsion for congenital lamellar ichtyosis and epidermolytic ichtyosis in children by Luiz, A Tomás, de la Cruz Murie, P, Jimenez, MDM Ruiz, Rivadeneyra, M Almanchel, Contreras, MC Muñoz, de la Rubia Nieto, MA

“…BackgroundTreatment of ichthyosis is based on disease severity, although a permanent cure may not yet be possible. Treatment options for ichthyosis include…”
Get full text

Síndrome de encefalopatía posterior reversible asociado al tratamiento con ivabradina: a propósito de un caso by Muros Ortega, M., Garrido Corro, B., Vidal Bugallo, J.B., de la Rubia Nieto, M.A.

Get full text

Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit by Casañ, Vicente Arocas, Escribano, Belén Cabezuelo, Garrido-Corro, Beatriz, Murie, Pablo de la Cruz, Álvarez, M.a José Blázquez, Nieto, M.a Amelia de la Rubia

“…To describe off-label and unlicensed drugs in clinical practice in a Neonatal Intensive Care Unit (NICU). The design of the study was a descriptive and…”
Get full text

Toxic epidermal necrolysis with fatal ending due to the concurrent use of carbamazepine, cilostazol and omeprazol: a case report by Concepción Martín, I, Fernández de Palencia Espinosa, M A, Garrido Corro, B, De La Rubia Nieto, A

Get full text

Supervivencia tras trasplante hepático por fallo hepático agudo debido a imatinib: a propósito de un caso by García-Valdés, M., Miras López, M., Garrido Corro, B., De La Rubia Nieto, A.

Get full text

Use of 2,3-dimercapto-1-propanesulfonic acid in a child with severe mercury-vapour poisoning by García-Valdés, M, Ortega-García, J A, Menéndez-Naranjo, L, de la Rubia Nieto, A

Get full text

Uso del ácido 2,3-dimercapto-1-propanosulfónico en un niño con intoxicación severa por vapor de mercurio by García-Valdés, M., Ortega-García, J.A., Menéndez-Naranjo, L., de la Rubia Nieto, A.

Get full text